Inhibiting Staphylococcus epidermidis Infections
- Technology Benefits
- Vaccine against S. epidermis would be prophylactic against infection, reducing morbidity and mortality associated with device-related infectionsReduces the requirement of antibiotics after implantation and thereby reduces the risk of developing antibiotic-resistant strain
- Technology Application
- Therapeutic agent for prevention or treatment of Staphylococcus epidermidis infections of implanted medical devicesMethod for development of antibodies against the collagen-binding protein, a key mediator of adherence to surface of devicesDevelopment of a prophylactic vaccine against S. epidermisAntibodies for passive immunization during S. epidermis infection
- Detailed Technology Description
- This invention describes a method for preventing or treating Staphylococcus epidermidis infections of implanted medical devices. This method involves the preparation of a therapeutic agent, such as a vaccine, antibody or peptide, developed against th...
- *Abstract
-
None
- *Inquiry
- Ron KatzColumbia Technology VenturesTel: (212) 854-8444Email: TechTransfer@columbia.edu
- *IR
- 2046
- *Principal Investigator
-
- *Web Links
- WIPO: International Patent Application WO/2008/088822
- Country/Region
- USA
For more information, please click Here

